Vanguard Global Advisers »

Century Therapeutics shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Century Therapeutics (IPSC) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Century Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Century Therapeutics held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Century Therapeutics by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $101k 45k 2.26

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Century Therapeutics

RA Capital Management
TCG Crossover Management
Versant Venture Management
Deep Track Capital
Commodore Capital
VR Adviser
Point72 Asset Management
Vanguard Capital Management
Balyasny Asset Management
Millennium Management
Woodline Partners
Seven Fleet Capital Management
Trails Edge Capital Partners
DAFNA Capital Management
Two Sigma Investments

View all funds holding Century Therapeutics